Chris Halpin

St George’s University Hospitals NHS Foundation Trust — United Kingdom

Neuroscience · Life Sciences

22h-index2.3kcitations46works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hearing, Cochlea, Tinnitus, Genetics(19), Neurofibromatosis and Schwannoma Cases(15), Meningioma and schwannoma management(14), Hearing Loss and Rehabilitation(13), Vestibular and auditory disorders(9)

Publications46 total

Perceptions, expectations and experiences of recovery before and after anterior cruciate ligament reconstruction: the patient voice – a protocol for a qualitative systematic review with meta-aggregation
BMJ Open·2025Open Access
Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2
Otology & Neurotology·2018· 19 cited
Current whole-body MRI applications in the neurofibromatoses
Neurology·2016· 85 citedOpen Access
Current status and recommendations for biomarkers and biobanking in neurofibromatosis
Neurology·2016· 22 citedOpen Access
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials
Neurology·2016· 45 citedOpen Access
Neurocognitive outcomes in neurofibromatosis clinical trials
Neurology·2016· 20 citedOpen Access
Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1
Neurology·2016· 18 citedOpen Access
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas
Journal of Clinical Oncology·2016· 128 citedOpen Access
Hearing and facial function outcomes for neurofibromatosis 2 clinical trials
Neurology·2013· 42 citedOpen Access
Tuning Fork Testing in Sudden Sensorineural Hearing Loss
JAMA Internal Medicine·2013· 30 cited
Audiology in the Sudden Hearing Loss Clinical Trial
Otology & Neurotology·2012· 16 citedOpen Access
Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2
Otology & Neurotology·2012· 245 citedOpen Access
Re-focussing on the clinical targets
Proceedings of the International Symposium on Auditory and Audiological Research·2011
Improvement in Word Recognition Score with Level Is Associated with Hearing Aid Ownership among Patients with Hearing Loss
Audiology and Neurotology·2011· 9 cited
Radiologic and Audiologic Evidence of the Location of an Intracochlear Mass
Otology & Neurotology·2010· 3 cited
Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients
Otology & Neurotology·2010· 101 citedOpen Access
Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
New England Journal of Medicine·2009· 519 citedOpen Access
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma
Journal of Neuro-Oncology·2009· 50 citedOpen Access
Article Commentary: Clinical implications of a damaged cochlea: Pure tone thresholds vs information‐carrying capacity
Otolaryngology·2009· 49 cited
Article Commentary: Hearing aids and cochlear damage: The case against fitting the pure tone audiogram
Otolaryngology·2009· 8 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Scott R. Plotkin(12), Fred G. Barker(10), Vanessa L. Merker(9), Gordon J. Harris(9), Amanda L. Bergner(8), D. Gareth Evans(8), Rosalie E. Ferner(8), Steven D. Rauch(7), Jaishri O. Blakeley(7), Laura M. Fayad(7), Shivani Ahlawat(7), Michael A. Jacobs(7), Eva Dombi(7), Staci Martin(7), Miriam A. Bredella(6), Wenli Cai(6), Srivandana Akshintala(6), Simone Ardern‐Holmes(6), Andrea Baldwin(6), Peter de Blank(6)